PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DAC vs. OLMA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


DACOLMA
YTD Return13.63%-15.47%
1Y Return28.04%-28.51%
3Y Return (Ann)9.36%-24.91%
Sharpe Ratio1.10-0.33
Sortino Ratio1.68-0.01
Omega Ratio1.201.00
Calmar Ratio0.31-0.29
Martin Ratio2.96-0.84
Ulcer Index8.85%29.26%
Daily Std Dev23.85%75.46%
Max Drawdown-99.42%-96.26%
Current Drawdown-80.34%-78.24%

Fundamentals


DACOLMA
Market Cap$1.59B$679.18M
EPS$29.29-$2.04
Total Revenue (TTM)$736.49M$1.88M
Gross Profit (TTM)$449.69M$1.61M
EBITDA (TTM)$340.85M-$98.02M

Correlation

-0.50.00.51.00.1

The correlation between DAC and OLMA is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

DAC vs. OLMA - Performance Comparison

In the year-to-date period, DAC achieves a 13.63% return, which is significantly higher than OLMA's -15.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
3.90%
5.49%
DAC
OLMA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DAC vs. OLMA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaos Corporation (DAC) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DAC
Sharpe ratio
The chart of Sharpe ratio for DAC, currently valued at 1.10, compared to the broader market-4.00-2.000.002.001.10
Sortino ratio
The chart of Sortino ratio for DAC, currently valued at 1.68, compared to the broader market-4.00-2.000.002.004.001.68
Omega ratio
The chart of Omega ratio for DAC, currently valued at 1.20, compared to the broader market0.501.001.502.001.20
Calmar ratio
The chart of Calmar ratio for DAC, currently valued at 0.72, compared to the broader market0.002.004.006.000.72
Martin ratio
The chart of Martin ratio for DAC, currently valued at 2.96, compared to the broader market-10.000.0010.0020.0030.002.96
OLMA
Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at -0.33, compared to the broader market-4.00-2.000.002.00-0.33
Sortino ratio
The chart of Sortino ratio for OLMA, currently valued at -0.01, compared to the broader market-4.00-2.000.002.004.00-0.01
Omega ratio
The chart of Omega ratio for OLMA, currently valued at 1.00, compared to the broader market0.501.001.502.001.00
Calmar ratio
The chart of Calmar ratio for OLMA, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.29
Martin ratio
The chart of Martin ratio for OLMA, currently valued at -0.84, compared to the broader market-10.000.0010.0020.0030.00-0.84

DAC vs. OLMA - Sharpe Ratio Comparison

The current DAC Sharpe Ratio is 1.10, which is higher than the OLMA Sharpe Ratio of -0.33. The chart below compares the historical Sharpe Ratios of DAC and OLMA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
1.10
-0.33
DAC
OLMA

Dividends

DAC vs. OLMA - Dividend Comparison

DAC's dividend yield for the trailing twelve months is around 3.91%, while OLMA has not paid dividends to shareholders.


TTM202320222021
DAC
Danaos Corporation
3.91%4.12%5.70%2.01%
OLMA
Olema Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%

Drawdowns

DAC vs. OLMA - Drawdown Comparison

The maximum DAC drawdown since its inception was -99.42%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for DAC and OLMA. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-14.48%
-78.24%
DAC
OLMA

Volatility

DAC vs. OLMA - Volatility Comparison

The current volatility for Danaos Corporation (DAC) is 7.34%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 11.36%. This indicates that DAC experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
7.34%
11.36%
DAC
OLMA

Financials

DAC vs. OLMA - Financials Comparison

This section allows you to compare key financial metrics between Danaos Corporation and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items